Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment

Rheumatology International, 04/23/2012

Two women with rheumatoid arthritis who had experienced miscarriages became pregnant while they were under etanercept treatment. One stopped etanercept after 3 weeks with increased doses of prednisolone, and the other restarted etanercept at a half doses 3 months later. They delivered a healthy baby at full term, and no problems in both expecting mothers and babies were observed. The use of etanercept in patients with rheumatoid arthritis seemed safe for pregnant mothers and their fetuses.

Print Article Summary Cat 2 CME Report